Description

Benzamide, n-[2-[(3-Cyano-8-Methyl-2-Quinolinyl)Amino]Ethyl]-3,4-Dimethoxy- (9Ci) is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant value in the research and development of novel therapeutic agents, particularly in the fields of oncology and targeted drug discovery. It is primarily sought after by pharmaceutical R&D laboratories, fine chemical manufacturers, and academic research institutions engaged in medicinal chemistry and process development.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of complex drug candidates, particularly those targeting specific enzyme pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new chemical entities (NCEs).
• Kinase Inhibitor Development: Serves as a core scaffold or precursor in the development of potential kinase inhibitors for cancer therapy.
• Fine Chemical Synthesis: Employed in multi-step organic syntheses to create specialized, high-value compounds for research purposes.
• Biochemical Research: May be used as a reference standard or probe in biochemical assays to study protein-ligand interactions.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and process development services.

Basic Information

Product Name	Benzamide, n-[2-[(3-Cyano-8-Methyl-2-Quinolinyl)Amino]Ethyl]-3,4-Dimethoxy- (9Ci)
CAS No.	606105-18-4
Molecular Formula	C22H22N4O3
Molecular Weight	390.44 g/mol
Synonyms	N-[2-[(3-Cyano-8-methyl-2-quinolinyl)amino]ethyl]-3,4-dimethoxybenzamide; 3,4-Dimethoxy-N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]benzamide; Benzamide, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-3,4-dimethoxy-; 606105-18-4; UNII-9F8I8C8K4F; 9F8I8C8K4F; SCHEMBL2180771; DTXSID60678469
EINECS	Contact for details

Quality Control

Our Benzamide, n-[2-[(3-Cyano-8-Methyl-2-Quinolinyl)Amino]Ethyl]-3,4-Dimethoxy- (9Ci) is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Each lot undergoes comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to confirm identity and purity. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting all critical quality attributes. We support cGMP compliance for advanced intermediates intended for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after each use to prevent degradation from atmospheric moisture. For long-term storage, consider using desiccants or storing under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.